Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells
Apply
SC-CAR.GPC3xIL15.21
Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step